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ABSTRACT 
Background  
The EQ-5D is a widely used questionnaire that describes and values health related 
quality of life. Recently, a five level version was developed. Updated methods to 
estimate values for all health states are required.  
Data  
996 respondents representative of the English general population completed Time Trade-
Off (TTO) and Discrete Choice Experiment (DCE) tasks.  
Methods  
We estimate models, with and without interactions, using DCE data only; TTO data only; 
and TTO/DCE data combined. TTO data are interpreted as both left and right censored. 
Heteroskedasticity and preference heterogeneity between individuals is accounted for. 
We use maximum likelihood estimation in combination with Bayesian methods. The final 
model is chosen using the deviance information criterion (DIC). 
Results   
Censoring and taking account of heteroskedasticity has important effects on parameter 
estimation. Regarding DCE, models with different dimension parameters and similar level 
parameters are best. Considering models for both TTO and DCE/TTO combined, models 
with parameters for all dimensions and levels perform best, as judged by the DIC. 
Taking account of heterogeneity improves fit, and a three latent group multinomial 
model has the lowest DIC.  
Conclusion   
Studies to elicit values for the EQ-5D-5L need new approaches to estimate the 
underlying value function. This paper presents approaches which suit the characteristics 
of these data and recognise preference heterogeneity. 
Keywords 
EQ-5D-5L; value set; health utilities; health-related quality of life; econometric 
modelling  
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1. Introduction  
Generic preference-based measures of health-related quality of life (HRQoL) have been 
developed primarily for use in the economic evaluation of health care technologies 
(Brazier et al., 2007). The EQ-5D is the most well-known and widely used generic 
preference-based measure (Devlin and Krabbe, 2013), with applications in clinical 
studies, reimbursement decision making, health care monitoring and population health 
studies. It comprises five dimensions: mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression. In the original version of the instrument, each 
dimension has three severity levels: no, some or extreme problems. In order to increase 
the instrument’s sensitivity to changes in health, a new version of the instrument with 
five levels on each of the five dimensions – the EQ-5D-5L – has been developed 
(Herdman et al., 2011).   
To generate country-specific EQ-5D value sets, general public respondents are asked to 
value a sub-set of health states described by the instrument. A number of different 
techniques can be used to obtain these values, such as standard gamble (SG), time 
trade-off (TTO) and visual analogue scale (VAS). They may also be derived indirectly 
using the discrete choice experiment (DCE) method, where values on a latent scale are 
derived from health state comparisons. To value the EQ-5D-5L in England we collected 
data from 996 individuals following a protocol developed by the EuroQol Group (Oppe et 
al., 2014) which comprises a combination of TTO and DCE tasks.  
van Hout and McDonnel (1992) presented the first EQ-5D value function, later published 
by van Busschbach et al (1999). Regression techniques were used to estimate the 
coefficients for each level and dimension, which could then be used to generate values 
for all of the health states described by the instrument. A number of issues related to the 
modelling approaches used to develop value sets that were relevant at that time are just 
as important now. Some of the issues are technical in nature, some are related to the 
way the questions in valuation tasks are asked, and some are more philosophical. An 
example of the latter is the question of whether the mean, mode or median should be 
used as the measure of central tendency when analysing health state values (Devlin and 
Buckingham, 2013). Is it really meaningful to take averages when some people value 
none of the health states below zero (i.e. as ‘worse than dead’) and others value nearly 
all of their health states below zero?  
The remainder of this paper reports the various modelling approaches developed to 
produce the EQ-5D-5L value set for England; the characteristics of the value sets 
produced from them; and the basis for selecting the final value set (reported in Devlin et 
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al., 2015). We begin by describing the data collection procedure, exclusion criteria and 
approaches to interpreting the data. We then describe a variety of models tested: those 
that use DCE data only; those that use TTO data only; and those that combine the TTO 
and DCE data. Special attention is paid to the error distribution in the TTO model, 
acknowledging the limited range of the data, the fact that the data are not really 
continuous, the fact that the variance increases with worsening health states, and 
preference heterogeneity. We also discuss the criteria used to select the “best” model. 
Findings are presented in the Results section, including modelling results from the 
various specifications as well as the sensitivity analysis. The final section discusses the 
improvements in econometric modelling methods developed in this study and compares 
these with methods used previously. 
 
2. Data 
In 2013 the EuroQol Valuation Technology (EQ-VT) – computer-assisted personal 
interview software – was developed by the EuroQol Group together with a protocol for 
the collection of EQ-5D-5L valuation data using TTO and DCE tasks (Oppe et al., 2014). 
For the TTO tasks, a composite approach (Janssen et al., 2013) was followed using 
“conventional” TTO for health states considered better than dead and “lead time TTO” for 
health states considered worse than dead (Devlin et al., 2013). Screenshots showing the 
way in which the composite TTO and DCE tasks were presented in the EQ-VT can be 
found in Oppe et al. (2014). The first four groups of researchers to use the EuroQol 
protocol collected data from samples of the general populations of China, England, 
Netherlands and Spain.  
 
2.1 Sampling 
Primary data collection was carried out in England by the market research company 
Ipsos MORI. The valuation data were collected via face-to-face interviews in 
respondents’ homes by 48 trained interviewers. A sample of 2,020 addresses from 66 
primary sampling units (based on postcode sectors) across England was randomly 
selected, using the Post Office small user Postcode Address File as the sampling frame. 
The sample was intended to be representative of adults aged 18 years and over living in 
private residential accommodation in England. A total of 1,004 individuals were 
interviewed between November 2012 and March 2013, with 996 completing the 
valuation tasks in full.    
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2.2 Study Design 
Eighty-six health states were valued using TTO. These were allocated to 10 blocks of 10 
states. Each block included the worst health state in the EQ-5D-5L descriptive system 
(55555) and one of the least severe health states. For the DCE tasks, 196 pairs of EQ-
5D-5L health states were selected and randomly assigned to 28 blocks of seven pairs. 
The selection of the health states is described elsewhere (Oppe et al., 2014; 
Pullenayegum and Xie, 2013). Each respondent completed 10 TTO and seven DCE tasks.    
 
2.3 Exclusion Criteria 
No DCE data were excluded from the modelling exercise. For TTO, 84 respondents were 
excluded because we judged their valuation data to be implausible. These include 23 
respondents who gave the same TTO value for all health states and 61 respondents who 
gave 55555 a value no lower than the value they gave to the mildest health state in 
their block. This was considered by the study team to represent a “clear inconsistency”.  
 
2.4 Final Data Set 
The final TTO data set includes 912 respondents with 9,120 TTO observations. Summary 
statistics for the TTO values for the 86 health states are reported in Table 1.   
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Table 1: Summary statistics for the 86 TTO health states 
Health 
state 
Obs Mean SD Min Max 
Health 
state 
Obs Mean SD Min Max 
21111 192 0.89 0.17 0 1 33253 99 0.40 0.45 -1 1 
11121 181 0.89 0.19 -0.20 1 54231 93 0.40 0.48 -1 1 
11211 173 0.89 0.18 0 1 23514 80 0.40 0.46 -1 1 
12111 184 0.87 0.21 0 1 31514 107 0.39 0.53 -1 1 
11112 182 0.85 0.23 -0.65 1 23152 85 0.39 0.43 -1 1 
11221 93 0.84 0.22 0 1 24342 99 0.36 0.51 -1 1 
21112 74 0.83 0.22 0 1 43514 85 0.36 0.53 -1 1 
11212 85 0.82 0.25 0 1 45133 80 0.36 0.51 -1 1 
13122 93 0.81 0.22 0.10 1 51152 93 0.35 0.55 -1 1 
12112 85 0.81 0.26 0 1 52215 80 0.35 0.48 -1 1 
12121 80 0.81 0.29 -1 1 45413 93 0.34 0.57 -1 1 
11122 91 0.79 0.28 0 1 45233 107 0.33 0.52 -1 1 
13313 107 0.69 0.33 -1 1 24553 93 0.33 0.50 -1 1 
14113 83 0.69 0.33 -0.90 1 52335 91 0.33 0.51 -1 1 
11421 107 0.65 0.38 -1 1 24443 83 0.33 0.47 -1 1 
12513 74 0.61 0.42 -1 1 12244 107 0.32 0.51 -1 1 
25222 107 0.59 0.38 -1 1 34515 93 0.32 0.55 -1 1 
35332 93 0.59 0.39 -1 1 12543 80 0.32 0.52 -1 1 
53221 74 0.58 0.42 -1 1 44125 74 0.32 0.51 -1 1 
34232 91 0.55 0.44 -1 1 32443 80 0.29 0.49 -1 0.95 
42321 91 0.54 0.44 -1 1 55233 107 0.28 0.58 -1 1 
52431 83 0.54 0.41 -1 1 35143 107 0.27 0.55 -1 1 
21315 83 0.54 0.46 -1 1 54153 83 0.27 0.48 -1 1 
25331 107 0.53 0.52 -1 1 51451 93 0.26 0.45 -1 1 
11235 93 0.53 0.42 -0.95 1 34244 85 0.26 0.48 -1 1 
22434 93 0.53 0.48 -1 1 55424 85 0.25 0.53 -1 1 
11425 93 0.53 0.48 -1 1 12344 74 0.25 0.50 -1 1 
25122 107 0.52 0.48 -1 1 34155 80 0.24 0.52 -1 1 
32314 99 0.51 0.46 -1 1 53243 107 0.23 0.58 -1 1 
35311 91 0.51 0.50 -1 1 43542 80 0.23 0.45 -1 0.95 
21334 99 0.50 0.43 -1 1 44345 74 0.21 0.50 -1 1 
13224 91 0.49 0.48 -1 1 35245 93 0.18 0.48 -1 1 
31524 83 0.45 0.47 -1 1 54342 74 0.18 0.55 -1 1 
12334 99 0.44 0.49 -1 1 55225 99 0.17 0.57 -1 1 
23242 99 0.44 0.47 -1 1 45144 93 0.17 0.44 -1 1 
53412 99 0.44 0.46 -1 1 24445 91 0.16 0.57 -1 1 
12514 93 0.44 0.48 -1 1 21444 107 0.15 0.52 -1 1 
31525 107 0.43 0.46 -1 1 14554 74 0.15 0.52 -1 1 
21345 85 0.43 0.47 -1 1 53244 107 0.12 0.53 -1 1 
43315 83 0.42 0.44 -0.95 1 44553 85 0.09 0.54 -1 0.95 
15151 83 0.42 0.45 -1 1 52455 107 0.07 0.57 -1 1 
11414 107 0.41 0.53 -1 1 43555 91 0.06 0.59 -1 1 
42115 93 0.41 0.48 -1 1 55555 912 -0.08 0.52 -1 0.95 
 
The final DCE data set includes 996 respondents with 6,972 observations. Each task 
involved a choice between two health states, labelled “A” and “B”. Among the 996 
respondents, five respondents always chose A and five always chose B. For each health 
state, a “level sum score” (sum of the levels of the five dimensions; a proxy for severity 
ranging from 5 (for 11111) to 25 (for 55555)) can be calculated. Figure 1 shows the 
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percentage of respondents who chose A, plotted against the differences in the sum score 
between the two options.  
 
Figure 1: Percentage choosing A or B in the DCE tasks versus relative severities 
of A and B (N=996) 
 
 
2.5 Interpretation of values at -1, 0 and 1.  
2.5.1    Censoring at -1 
When respondents completing a TTO task judge a health state – say “x” – to be worse 
than dead they may, at the extreme, prefer to die now than to live for 10 years in full 
health (the lead time) followed by 10 years in “x”. In that case the resultant value, given 
the variant of TTO used in the EQ-5D-5L valuation protocol, is -1. However, we cannot 
exclude the possibility that respondents who respond in this way would have traded 
more time in full health had they been presented with a longer lead time, in which case 
their value is lower than -1 (Devlin et al., 2013). As such, when a value of -1 is observed 
it can be interpreted as -1 or lower, which makes these values, in a statistical sense, 
“left censored” at -1.  
 
2.5.2    Censoring at 0 
When the TTO data for each respondent were plotted against the predicted TTO values 
from the 10 parameter DCE tariff, we found that most respondents’ data followed a 
negative gradient as expected (i.e. valuing more severe health states lower than less 
severe health states). However, some respondents use zero as the minimum value more 
than once, including when valuing the worst health state 55555. This suggests that 
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those respondents did not want to go below zero (i.e. do not believe there is such a 
thing as a health state so bad that experiencing it for 10 years would be worse than 
being dead). Consequently, these respondents do not distinguish between 55555 and 
other health states which are logically better (55555 is dominated by all other EQ-5D-5L 
health states), leading to a situation in which no value is attached to improvements from 
55555 to less severe health states. With hindsight it was interpreted that when a 
respondent valued more than one health state (almost always including 55555) at zero 
that these values are not necessarily equal. This is captured by interpreting the observed 
zero values as being either zero or less than zero. In statistical terms, those zeros are 
interpreted as being “censored at zero”. This concerns 150 respondents and 595 
observed zero values.  
Further, a number of respondents valued 55555 at zero whilst valuing more than one 
other health state at less than zero. This is logically inconsistent. Either the values below 
zero should be higher, or the value of 55555 should be lower. We know the direction of 
the error but not the magnitude. We censored those negative values and associated zero 
values at zero. This concerns 27 individuals and 154 observations.  
Figure 2 shows the number of observations for each TTO value. The red bars show the 
number of observations censored at zero. In total we censored 749 observations (154 + 
595 = 749) at zero.  
Figure 2: Number of observations censored and not censored at zero against 
the TTO value 
 
1: Red bars show the number of observations that are censored at zero for each TTO value.  
2: Blue bars show the number of observations that are not censored at zero for each TTO value.
 11 
 
  
 
2.5.3    Censoring at 1 
Some respondents gave relatively low values, e.g. 0.5 or 0, to the least severe states 
resulting in relatively large differences between the mean and the median value. For 
example, the mean and median for health state 11211 are 0.95 and 0.89 respectively. 
Respondents could make errors in the composite TTO tasks, defined as the deviation of 
the observed from the true TTO value. While one can make an error to the left and value 
this health state at 0, one cannot make an equivalent error to the right and score it at, 
say, 2. So, the error distribution is likely not to be normally distributed, which also 
explains why the mean and median are quite different. Now, imagine the TTO scale as 
viewed by respondents with 1 on the right and 0 towards the left. When valuing a given 
health state they may imagine the state, and look to place it on the TTO scale. If 
respondents make errors to the left, the state ends up with an observed value which is 
lower than the true value (and this observed value can be as low as -1). If respondents 
make errors to the right, the maximum value they can give is 1. Therefore, values at 1 
could be considered as being either 1 or greater than 1 (i.e. ”right censored”). To censor 
TTO data at 1 might be considered arbitrary. However, to assume the errors follow a 
normal distribution is incorrect as the assumption denies the fact that the theoretical 
TTO values could exceed 1.  
 
3. Methods   
Both TTO and DCE data can be used individually to produce a value set. We present 
results using DCE data, TTO data, and TTO/DCE data combinations.    
 
 Model parameter specification 3.1
Within each method, models were estimated with 5, 9, 10 and 20 parameters, with and 
without interaction terms, and with and without terms capturing some degree of 
decreasing marginal severity, corresponding with the “N3 term” used in the 3-level UK 
tariff (Dolan, 1997).  
The 5 parameter model estimates one parameter for each dimension. The level 
descriptors (no, slight, moderate, severe, extreme/unable problems) are captured by 
five numbers respectively, i.e. 0, 1, 2, 3 and 4. The assumption behind this model is that 
there is a linear relationship between the TTO values and the five dimensions. Within 
each dimension, the utility decrements for moderate problems are assumed to be twice 
as large as for slight problems, the utility decrements for severe problems are assumed 
to be three times as large as for slight problems, etc.  
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The 9 parameter model estimates one parameter per dimension and one parameter per 
level (4 levels + 5 dimensions = 9 parameters). In theory, the 5 dimension parameters 
could add up to one. To save the degrees of freedom, we actually estimate 4 dimension 
parameters rather than 5. Therefore, the 9 parameter model could be viewed as an 8 
parameter model (4 levels + 4 dimensions = 8 parameters) with the additional 
dimension parameter constrained. The assumptions behind this model is that there is a 
linear relationship between the TTO values and the five dimensions. The impact of each 
level is the same across all five dimensions.  
Unlike the 9 parameter model, the 10 parameter model estimates two parameters for 
level 5 (one for the mobility, self-care and usual activity dimensions where level 5 
describes being “unable” to do a certain function; the other for the pain/discomfort and 
anxiety/depression dimensions where level 5 described having ”extreme” problems). As 
in the 9 parameter model, we estimate 4 dimension parameters. Therefore we actually 
estimate 9 parameters with one dimension parameter constrained instead of 10 
parameters.    
The 20 parameter model estimates four parameters for each dimension and one 
parameter per level, with the “no problems” level used as the baseline (4 levels x 5 
dimensions = 20 parameters). This model allows the coefficients to differ between 
dimensions, and for the importance of each level of problems to differ between 
dimensions.  
Below we use the 20 parameter model without interactions to illustrate our methods.  
 
 Modelling the discrete choice data 3.2
When considering the DCE data, respondents compare the utilities of two health states, 
i.e. Vijl and Vijr. The Vijl comes from individual i for health state presented on the left 
hand side l within DCE pair j.  We formulate the comparison in equation (1): 
 
When assuming that the errors are normally distributed the parameters can be 
estimated by maximum likelihood as in a probit model. When assuming that the errors 
follow an extreme value distribution the parameters can be estimated by maximum 
likelihood as in a logistic regression. A constant term that is significantly different from 
zero suggests an overall preference for the health state appearing either on the left or 
on the right hand side. We use the logistic regression, as we assume that errors in 
(1)      ?
20
1
20
1
rj
i
k
rj
kkrijr
lj
i
k
lj
kklijl exVexV  


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equation (1) may show extreme values. For instance, respondents could value severe 
health state as negative infinity.  
 
 Modelling the TTO data 3.3
When modelling the DCE data the parameters only have a relative value. It provides 
information on the relative preference of one health state over another. When using TTO 
data, the parameters can be interpreted as measuring a deviation from full health on a 
scale anchored at 1 (representing full health) and 0 (the value for dead). As with DCE we 
assume a value function that is linear between the value and the description of the 
health state. The specification is shown by equation (2).  
 
 
 
𝑉𝑖
𝑗
 is the TTO value for health state j from respondent i. Parameters 𝛽𝑘  reflect the real 
decrement from full health. The error term 𝑒𝑖
𝑗
 measure the difference between an 
observed TTO value and the mean value. It captures random errors as well as 
differences of opinion between respondents about health states. In a linear regression 
analysis, the random error term is assumed to follow a normal distribution with mean of 
zero and constant variance. We follow this assumption but, as indicated above, there 
may be censoring at -1, 0 and 1.  
 
Three further issues require consideration. First, it is observed that the variance of TTO 
values is larger for poorer health states than for better health states. This is due to a 
divergence in preferences regarding these states, but also increased respondent error. 
Second, there is the pseudo continuity of the data – only 41 unique values between -1 
and 1 are available to respondents. Third, we limit the parameter space such that 
coefficients are always logically consistent.  
 
    Heteroskedasticity/heterogeneity  3.3.1
The variation of TTO values between more severe and less severe states means that the 
error terms in modelling the TTO data show heteroskedasticity. One explanation is that 
values for the mildest health states could sensibly be in a relative narrow range of 0.8 
and 1 for example, whereas the sensible range of values for the more severe health 
states could be much larger, e.g. between -1 and 0.5. This is because respondents could 
use 1 as a baseline to value the mildest health states. However, for severe health states, 
(2)      )(1
20
1
j
i
k
j
ikk
j
i exV  


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respondents apply their own scale and there is no baseline value to use. They can score 
any value between -1 to 1. The heteroskedasticity is captured by applying a linear 
relationship between the variance and the mean of the error terms per health state, 
adding two parameters to the model. A negative linear relationship between the mean 
and variance of the error terms indicate that the respondents use a smaller range of TTO 
values for mild health states than severe health states.  
 
An alternative and probably more fundamental way of capturing the increasing variance 
in the error terms with the increasing level of severity in health states is to take into 
account the heterogeneity of respondents’ opinions. We observe that respondents 
effectively use different TTO scales, e.g. some respondents never give negative TTO 
values, some give both negative and positive TTO values, and some express “extreme” 
views about some health states. It is expected that respondents disagree more about 
severe health states than milder health states. The heterogeneity of TTO scales that 
respondents used could be explained by the disagreement about the value of dead 
between respondents. This is captured by introducing a parameter for disutility scale 𝛾, 
which may differ between respondents. The specification is reported by equation (3).  
 
We investigate three assumptions of the distribution in 𝛾: (i) a normal distribution with 
mean 1 and a variance which needs to be estimated; (ii) a lognormal distribution with 
mean 1 and a variance which needs to be estimated; and (iii) a multinomial distribution 
with probability density on a number of discrete values. It is envisaged that the tail in 
the lognormal distribution may capture some respondents with extreme values. The 
multinomial model corresponds with the notion that there may be a number of latent 
groups, each having their own mean and variance. In our analysis, we experimented the 
number of probability density that equals to 2, 3 and 4.  For normalisation, the mean 
value of 𝛾 for one of the three latent groups has value constrained to 1. Within this 
model, we also assume that there is heteroskedasticity which may be different per 
group.      
 
 Continuity of the TTO data 3.3.2
Given the study protocol (and the iteration used to arrive at a point of indifference– see 
Oppe et al., 2014), respondents can only give 41 distinct values. These range from -1 to 
1 with steps of 0.05 between each distinct value. Apart from the two boundary values -1 
and 1, for each observed TTO value x we assume that the true value lies within the 
range [x-0.025, x+0.025]. The value 0.025 is the mid-point of the gap between two 
(3)      )(1
20
1
j
i
k
j
ikki
j
i exV  


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neighbouring TTO values. For instance, when a respondent gives the value 0.5, the true 
value could be in a scale of 0.475 and 0.525 which are the midpoints of the nearest 
available values 0.45 and 0.55. More subtle rules to define the true scale for observed 
TTO values are possible. These rules depend on the process by which respondents arrive 
at their TTO values. In our case, the mid-point was considered an appropriate rule for 
defining the scales for observed values.  
 
We analyse how the standard censored model changes when we treat TTO data as non-
continuous (or interval censoring). The interval censoring triggers the question about 
how to censor TTO values at -1 and 1. When we observe a TTO value at 1, the true value 
could be in a scale of 0.975 and 1. Instead of censoring the TTO value at the top end of 
1, we censored it at 0.975 when modelling the TTO data as non-continuous variable. The 
same analysis was applied to the bottom end. Therefore, we censored TTO data at -
0.975 rather than -1 when modelling the TTO data as non-continuous.  
 
  Forcing consistency 3.3.3
The parameter for the “moderate” level is expected to be larger than that for “slight” and 
lower than that for “severe”, etc. However, when estimating the parameters freely, 
“logically inconsistent” estimates may be observed. It is hypothesized that while 
respondents may not always distinguish between different levels, they do not reverse 
the ordering. The estimated parameters should be logically consistent if respondents 
could correctly distinguish between different levels. The parameter space is used to 
reflect this. When defining our preferred models, this is captured by first estimating the 
parameters for the “slight” levels and then estimating those for the more severe levels 
by subsequently adding quadratic terms (which can only be zero or positive).   
 
 Hybrid model 3.4
Both the TTO and DCE data provide information about the values of health states. If the 
same value-function dictates the answers to both types of question, one would expect 
the coefficients to be identical except for the constant term. Both the TTO and DCE tasks 
measure the relative decrements of health utility from full health. Following a likelihood 
approach (Rowen et al., 2014), estimated coefficients for different dimensions and levels 
can be obtained by including the constant term into the likelihood function of the DCE 
data and then optimising the likelihood function of the DCE and TTO data. Alternatively, 
following a Bayesian approach, one may consider both DCE and TTO data in one model 
with the same coefficients and including a constant term into the DCE model to allow for 
proportional differences.  
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  Criterion for the ‘best’ model selection 3.5
With respect to models estimated from DCE data only, we choose the best model on the 
basis of the maximum likelihood statistics. We also use the maximum likelihood to 
compare the performance of TTO models that take account of the heteroskedasticity. For 
the models accounting for heterogeneity, we use the deviance information criterion 
(DIC) to compare performance. The best hybrid model with heteroskedasticity and best 
hybrid model with heterogeneity are compared using the DIC. The coefficient ordering 
and the face validity of the value range are also compared.  
 
It should be noted that the “best” model is not necessarily expected to predict the mean 
observed values from the TTO data the best. That is because some observations are 
censored, and as a result the mean is not the best measure of central tendency. 
Furthermore, we use not only the TTO data but also the DCE data in the hybrid model, 
whereas observed values are available only from TTO data.   
 
 Sensitivity analyses 3.6
Four sensitivity analyses are conducted to check the robustness of the 20 parameter 
hybrid model results. Each analysis reveals the impact of one – potentially arbitrary – 
decision we made. The first sensitivity analysis checks the impact of exclusion criteria on 
the value set. We run the hybrid model without excluding any TTO observations from the 
data set (section 2.3). The second sensitivity analysis checks the impact of censoring the 
TTO data at -1, 0 and 1 (section 2.5).  
 
R 3.2.0 and WinBugs14 were used for the modelling analysis. 
 17 
 
  
 
4. Results 
The results for the 5, 9 and 10 parameter models for the DCE, TTO and combined 
datasets are reported in Table 2. The 5 parameter model offers a first impression of 
which dimensions get the highest weight, i.e. pain/discomfort followed by 
anxiety/depression. The DCE data indicate a higher weight for mobility than for usual 
activities and self-care, whereas the TTO data give approximately equal weights for 
mobility and usual activities.  
Table 2: Estimates using the 5, 9 and 10 parameter models  
  TTO-data DCE-data All-data 
5 parameter model Coeff se Coeff se Coeff se 
mobility 0.052 0.004 0.338 0.016 0.061 0.002 
self-care 0.046 0.004 0.241 0.014 0.045 0.002 
usual activities 0.053 0.004 0.205 0.015 0.044 0.002 
pain/discomfort 0.078 0.004 0.406 0.016 0.078 0.002 
anxiety/depression 0.077 0.004 0.393 0.015 0.078 0.002 
Log likelihood -28,840.15   -3,860.29   -32,709.51   
9 parameter model Coeff se Coeff se Coeff se 
mobility 0.185 0.012 0.214 0.007 0.204 0.006 
self-care 0.166 0.011 0.166 0.007 0.165 0.006 
usual activities 0.157 0.011 0.136 0.007 0.143 0.006 
pain/discomfort 0.249 0.011 0.243 0.008 0.243 0.006 
anxiety/depression 0.242   0.241   0.244   
slight 0.263 0.020 1.478 0.139 0.290 0.015 
moderate 0.482 0.027 1.777 0.144 0.409 0.016 
severe 1.147 0.029 5.424 0.183 1.120 0.019 
unable/extreme 1.183 0.020 6.295 0.192 1.228 0.017 
Log likelihood -28,801.61   -3,743.85   -32,561.91   
10 parameter model Coeff se Coeff se Coeff se 
mobility 0.176 0.011 0.215 0.008 0.202 0.006 
self-care 0.153 0.011 0.167 0.008 0.162 0.006 
usual activities 0.140 0.012 0.137 0.008 0.140 0.006 
pain/discomfort 0.264 0.013 0.241 0.009 0.248 0.007 
anxiety/depression 0.266   0.239   0.249   
slight 0.253 0.020 1.479 0.139 0.288 0.015 
moderate 0.466 0.027 1.779 0.144 0.406 0.017 
severe 1.129 0.029 5.430 0.183 1.116 0.020 
unable 1.388 0.066 6.217 0.246 1.266 0.034 
extreme 1.032 0.042 6.363 0.237 1.195 0.027 
Log likelihood -28,794.93   -3,743.72   -32,560.84   
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The 9 parameter model offers a significant improvement according to the likelihood ratio 
test and we observe – in both the DCE and the TTO data – that the decrement from 
slight to moderate and from severe to unable/extreme are much smaller than the 
decrement from moderate to severe. Having different parameters for level 5 based on 
descriptor improves the TTO model but not the DCE model. The parameter for unable is 
larger than that for severe in all three 10 parameter models but the parameter for 
extreme is not in the TTO model, which suggests an “inconsistency”.   
 
The results for the 20 parameter model are presented in Table 3. Here, we include the 
model where the parameter space is restricted. When using a likelihood ratio test to 
compare the 20 parameter model with the 10 parameter model we find a significant 
improvement when estimating using the TTO data but not when only using the DCE 
data. The results are characterised by two logical inconsistencies: one between levels 4 
and 5 on the usual activities dimension, and one between levels 4 and 5 on the 
anxiety/depression dimension. By design, such inconsistencies are not present when 
limiting the parameter space and we find that this can be achieved without affecting the 
likelihood of the data (i.e. log likelihood=-32,062). Also the coefficients of the two value 
sets changed little (last two columns of Table 3).  
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Table 3: 20 parameters model with and without restriction  
  TTO-data DCE-data All-data  
All data 
restricted 
parameter space 
mobility 
estimate se estimate se estimate se estimate se 
slight 0.033 0.013 0.347 0.057 0.057 0.008 0.056 0.008 
moderate 0.068 0.017 0.444 0.068 0.078 0.010 0.078 0.010 
severe 0.194 0.019 1.130 0.068 0.214 0.010 0.213 0.010 
unable 0.237 0.018 1.438 0.075 0.263 0.010 0.262 0.010 
self-care 
                
slight 0.053 0.012 0.261 0.061 0.058 0.008 0.058 0.008 
moderate 0.067 0.017 0.401 0.067 0.081 0.010 0.081 0.010 
severe 0.140 0.018 1.000 0.068 0.183 0.010 0.182 0.010 
unable 0.235 0.017 1.045 0.065 0.215 0.009 0.214 0.009 
usual activities                 
slight 0.050 0.013 0.211 0.058 0.046 0.008 0.046 0.008 
moderate 0.110 0.016 0.217 0.065 0.068 0.009 0.068 0.009 
severe 0.185 0.017 0.798 0.065 0.172 0.009 0.170 0.008 
unable 0.165 0.018 0.815 0.067 0.167 0.009 0.170 0.018 
pain/discomfort                 
slight 0.054 0.011 0.333 0.062 0.058 0.008 0.058 0.008 
moderate 0.066 0.018 0.381 0.065 0.080 0.010 0.080 0.010 
severe 0.284 0.018 1.192 0.068 0.253 0.010 0.253 0.010 
extreme 0.306 0.019 1.584 0.070 0.307 0.011 0.306 0.011 
anxiety/depression 
                
slight 0.076 0.012 0.334 0.064 0.071 0.008 0.071 0.008 
moderate 0.130 0.017 0.378 0.066 0.099 0.010 0.098 0.009 
severe 0.315 0.017 1.350 0.072 0.290 0.010 0.287 0.008 
extreme 0.272 0.016 1.468 0.071 0.286 0.010 0.288 0.021 
log likelihood -28,306 -3,731 -32,062 -32,062 
 
 
Table 4 reports three all data 20 parameter models. The TTO data is treated as a 
continuous variable. The heterogeneity of respondents is captured in the models by 
assuming that respondents use different slopes of disutility in health (or different 
assumptions of distribution for parameter 𝛾 in equation 3).  
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Table 4: Estimates using all data 20 parameter model with different slope 
distributions 
  normal slope lognormal slope multinomial slope  
mobility mean sd Mean sd mean sd 
slight 0.054 0.008 0.051 0.009 0.051 0.004 
moderate 0.074 0.010 0.070 0.010 0.063 0.004 
severe 0.208 0.011 0.212 0.010 0.212 0.006 
unable 0.254 0.011 0.263 0.011 0.275 0.006 
self-care             
slight 0.060 0.008 0.060 0.008 0.057 0.004 
moderate 0.083 0.010 0.080 0.010 0.076 0.004 
severe 0.177 0.010 0.182 0.010 0.181 0.005 
unable 0.211 0.009 0.220 0.010 0.217 0.005 
usual activities             
slight 0.049 0.008 0.047 0.009 0.051 0.004 
moderate 0.075 0.009 0.068 0.009 0.067 0.004 
severe 0.170 0.008 0.172 0.009 0.174 0.005 
unable 0.175 0.009 0.180 0.009 0.190 0.005 
pain/discomfort             
slight 0.062 0.008 0.058 0.009 0.060 0.004 
moderate 0.086 0.010 0.086 0.010 0.075 0.005 
severe 0.260 0.010 0.269 0.011 0.276 0.007 
extreme 0.318 0.011 0.333 0.012 0.341 0.008 
anxiety/depression             
slight 0.090 0.008 0.088 0.008 0.079 0.004 
moderate 0.125 0.011 0.126 0.010 0.104 0.005 
severe 0.297 0.009 0.307 0.010 0.296 0.007 
extreme 0.299 0.009 0.310 0.010 0.301 0.007 
Variance 2.980 0.198 2.993 0.175     
P(group1)         0.397 0.019 
P(group2)         0.270 0.018 
P(group3)         0.333 0.018 
slope (group 1)         0.427 0.031 
slope (group 2)         0.939 0.067 
slope (group 3)         1.635 0.017 
DIC 17,286 16,908 15,593 
 
In Table 4, we report the results for 3 latent groups in the multinomial slope model. The 
multinomial slope model divides all respondents into 3 latent groups which is based on 
the similarity of their slopes. Increasing the number of groups from 3 to 4 in the 
multinomial model did not improve the estimates.  
 
The DIC is used to compare the performance between all-data-20 parameter models. 
The DIC for model without heterogeneity but with heteroskedasticity is 19,930. It 
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indicates that the three random slope models, which reported in Table 4, offer an 
improvement. The lowest DIC is achieved in the all-data-20-parameter multinomial slope 
model, i.e. 15,593. This model is therefore considered as the best performing model for 
data from the EQ-5D-5L value set for England project. This includes a further 
improvement that is achieved by capturing heteroskedasticity using two parameters per 
group to model the dependency between the variance per health state and the mean per 
health state.   
 
Figure 3 illustrates the predicted utilities and observed TTO for the 4 all-data-20 
parameter models. Predicted utilities for the 86 health states in Figure 3.1 used all data 
restricted parameter space model (Table 3). Predicted utilities in Figure 3.2 used normal 
slope model (Table 4). Predicted utilities in Figure 3.3 used lognormal slope model (Table 
4). Predicted utilities in Figure 3.4 used multinomial slope model (Table 4). 
 
3.1: All data restricted parameter space model  3.2: Normal slope model  
                   
3.3: Lognormal slope model                           3.4: Multinomial slope model  
         
When comparing the estimates of the least severe and worst health states from all 
models we find that the prediction of 11211 (slight problems in usual activities and no 
problems on any other dimension) and 21111 (slight problems in mobility and no 
problems on any other dimension) score above 0.95. This is higher than the mean 
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observed values of 0.89, which we believe to be biased due to the asymmetry of the 
error distribution. The score for 55555 varies across models: -0.240 for the model 
without heterogeneity, -0.257 for the normal slope model, -0.306 for the lognormal 
slope model, and -0.281 for the multinomial slope model. The lower values reflect the 
potential of the latter two models to capture more extreme values.   
We made a number of decisions about how to interpret the data, and these were 
subjected to sensitivity analysis. Table 5 presents results of the 20 parameter hybrid 
model if we hadn’t made those decisions. Column 2 shows the results if we had not 
applied any exclusion criteria to the raw data set. Hence, there are 996 individuals 
included in the analysis. Health state 11211 (i.e., slight problem with usual activities and 
no problem in any other four dimensions) has the highest value of 0.956. The lowest 
value is reported as -0.201 for health state 55555. Columns 3 to 6 reports four sets of 
results from the sensitivity analysis without censoring: column 3 shows the results 
without censoring at -1; column 4 without censoring at 1; column 5 without censoring at 
0; and column 6 shows the results if there was no censoring at all. Calculations from the 
four sets of results in columns 3 to 6 all suggest that health state 11211 has the highest 
value. Only for results that are reported in column 4, i.e. without censoring at 1, suggest 
that health states 21111 and 11211 have the same value. The value for health state 
11211 is 0.951 if the TTO data are not left censored at -1; 0.934 if TTO data are not 
right censored at 1; 0.953 if the TTO data are not censored at zero; and 0.935 if the TTO 
data are not censored at all. The lowest value is for health state 55555. It is reported as 
-0.201 if the TTO data are not left censored as -1;  -0.271 if the TTO data are not right 
censored at 1; -0.162 if the TTO data are not censored at zero; and -0.131 if the TTO 
data are not censored at all. 
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Table 5. Effects of different interpretations of the hybrid model data 
 
  no exclusions 
no censoring 
at -1 
no censoring 
at 1 
no censoring 
at 0 
no censoring 
at all 
Mobility coeff se coeff se coeff se coeff se coeff se 
slight 0.060 0.008 0.059 0.008 0.066 0.007 0.058 0.008 0.066 0.007 
moderate 0.076 0.010 0.082 0.010 0.079 0.009 0.078 0.009 0.079 0.008 
severe 0.204 0.010 0.209 0.009 0.211 0.009 0.201 0.009 0.195 0.008 
unable 0.253 0.010 0.253 0.009 0.253 0.010 0.241 0.009 0.225 0.009 
self-care                     
slight 0.050 0.008 0.058 0.008 0.082 0.006 0.060 0.008 0.079 0.007 
moderate 0.072 0.010 0.081 0.010 0.094 0.018 0.081 0.010 0.087 0.009 
severe 0.170 0.010 0.178 0.010 0.197 0.018 0.171 0.009 0.175 0.009 
unable 0.201 0.009 0.202 0.009 0.231 0.017 0.198 0.009 0.198 0.009 
usual activities 
                    
slight 0.044 0.008 0.049 0.008 0.066 0.007 0.047 0.008 0.065 0.007 
moderate 0.061 0.009 0.069 0.009 0.085 0.008 0.067 0.009 0.083 0.008 
severe 0.161 0.008 0.164 0.007 0.182 0.007 0.160 0.007 0.167 0.007 
unable 0.171 0.017 0.173 0.014 0.186 0.009 0.166 0.012 0.169 0.007 
pain/discomfort 
                    
slight 0.058 0.008 0.057 0.008 0.078 0.006 0.057 0.008 0.076 0.006 
moderate 0.078 0.010 0.081 0.009 0.088 0.011 0.081 0.009 0.088 0.008 
severe 0.242 0.010 0.246 0.010 0.248 0.011 0.233 0.009 0.223 0.009 
extreme 0.293 0.010 0.290 0.010 0.302 0.011 0.280 0.009 0.266 0.009 
anxiety/depression 
                    
slight 0.070 0.008 0.071 0.008 0.097 0.006 0.072 0.008 0.095 0.006 
moderate 0.097 0.009 0.100 0.009 0.111 0.009 0.099 0.009 0.111 0.008 
severe 0.273 0.008 0.277 0.008 0.294 0.007 0.269 0.007 0.271 0.007 
extreme 0.283 0.016 0.283 0.012 0.299 0.010 0.277 0.013 0.273 0.008 
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5. Discussion and Conclusions 
The primary aim of this study was to adapt the modelling methods that were used to 
produce value sets for EQ-5D which correspond to the newly designed elicitation 
method, comprising a different type of TTO and with the addition of DCE. Additionally, a 
number of developments in the modelling approaches were made, compared to earlier 
approaches, which bring the models closer to the nature of the data.  
The new study design combined TTO data with DCE data. The lead time TTO approach 
was used which meant that the minimum value respondents could score was -1 without 
information about whether that value or a lower value was respondents’ genuine 
preference. The data were seen as censored and the true value were not observed. 
Therefore, an assumption should be made for the (left tail of the) distribution of the TTO 
data. We experimented model that assumed a normal distribution with errors and 
accounting for the heteroskedasticity. And when experimenting models that account for 
the heterogeneity of respondents, the assumption of normal distribution for errors is still 
applied. With the heterogeneity models, we experimented the assumptions of slope for 
disutility in health with a normal distribution, lognormal distribution and a multinomial 
distribution. Our results suggest that the assumptions of distributions affects the value of 
poor health states, as well as the predicted TTO values in particular for values where the 
real data points in our data set is limited. In contrast, the respondents in the 
Measurement and Valuation of Health (MVH) study could score TTO value as low as -39. 
In order to minimise the effect of extreme values, a decision was taken to rescale the 
TTO values to a range of [-1, 1]. It suggests that the extreme negative values in TTO 
are possible. Indeed, some respondents may not want to end – coûte que coûte – in 
certain health states and their values may have great impact on the averages. The 
solution may be to use medians or to exclude extremes at both the lower and upper end 
of the scale.  
We also censored data at the upper-end of the TTO scale. It does not suggest that we 
believe the true TTO values are higher than one, but rather a combination of the true 
value and an error term which follows a normal distribution. The observed average TTO 
value for the mild health states is clearly too low. These values might be unable to 
reflect the true average value for mild states in the English population. Fitting the TTO 
data into a normal distribution with assumption of right censored at 1 (which is not too 
different from taking the median) could better represent the “real” average values. It is 
therefore arguable that the TTO values for mild health states in the MVH study were too 
low, as those data are also right censored at 1.  
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Another aspect which has been given attention is the fact that the TTO data are not 
really continuous, as respondents can only give 41 distinct values. Therefore, when a 
respondent scores 0.9, instead of 0.85 or 0.95, it might indicate that the true value 
locates in a scale between 0.925 and 0.975. Furthermore, respondents have a digit 
preference. They are more likely to end up with 0.1, than 0.05 or 0.15 for example. We 
used the simple correction for our heteroskedasticity model by censoring the upper end 
of TTO value at 0.975 rather than 1. In together with the left censoring at -0.975, this 
censoring exercise is also applied to the heterogeneity models, which are estimated 
without defining intervals for other TTO values. This characteristic of the TTO data was 
not recognised by the MVH study, although respondents could score more (80) unique 
values.   
With the addition of the DCE data, we choose to combine the information into a single 
likelihood function and assuming that the underlying preference function which dictates 
the answers to the DCE comparisons also dictates the answers to the TTO questions. It 
should be noted that the DCE data is under the assumption that errors, or differences of 
opinion, are normally distributed. It might be true for errors, however it is unlikely to be 
true for differences in opinion. In the multinomial model, we identify a group of 
respondents who always score positive values, a group of respondents who score both 
positive and negative values, as well as a group of respondents with extreme values. The 
DCE data, in this design, are not rich enough to pick up such clear differences. 
Therefore, estimations that are based on DCE data only might be criticised by such an 
assumption with the error distributions. However, different from some of the findings of 
modelling TTO data only, all parameters in the DCE modelling results were logically 
consistent. Also the results from the DCE models show the general structure of the value 
set, i.e. with small steps between slight and moderate levels, big steps between 
moderate and severe level, and again small steps between severe and extreme/unable 
levels. It is observed that the TTO data and the DCE data lead to different parameter 
estimates. The TTO data seems to be the closest to the decision making context where 
trade-offs need to be made between length of life and quality of life. One may criticize 
the error distribution of the DCE model, but this may also apply to the TTO data.  
The last remark refers to our decision to censor some of the data at zero. Some 
respondents used zero multiple times as their minimum value. That information, i.e. all 
such states have a value equal to dead, does not help with prioritisation between quality 
and length of life. Some respondents show clear inconsistencies, scoring health state 
55555 at zero and more than one other state at below zero. One solution is to consider 
an error distribution which recognised this data issue in a creative way or interprets the 
data as a range rather than a value. We regret that such rather arbitrary judgement had 
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to be made and feel that this is a consequence of having an outside agency doing the 
interviews with strict guidance not to interfere, even when one might think that this is 
needed.  
Another aspect which may need further justification is that we formulated rather vague 
prior distributions which guaranteed that the differences between the levels were 
positive. Indeed when estimated without constraint, the TTO data may suggest that the 
severe level (level 4) is worse than extreme level (level 5) in the anxiety/depression 
dimension. We don’t find this in the DCE data, and one explanation for this may relate to 
the selection of the 86 health states in the TTO exercise. Additionally, we find 
justification of our priors by referring to the research that underlying the choice of the 
labels in the EQ-5D-5L (Luo et al., 2015).    
At the end we find that a model which splits the population into three groups of 
preference ‘types’  appealing both intuitively and in terms of statistical performance of 
the models. The result captures the idea that the groups have different attitudes toward 
death when prioritising quality and length of life. This may help people identify 
themselves when considering the outcomes of a value function. The final model is not 
one model for all; rather, it is a compromise of different opinions, statistics, and trying to 
capture the opinions of a nation with different - sometimes very different - opinions.  
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